Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Novavax, Inc.
  6. News
  7. Summary
    NVAX   US6700024010

NOVAVAX, INC.

(NVAX)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-27 pm EST
11.29 USD   +2.82%
01/26FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/26Novavax needs 6 months to produce annual COVID shots that match new variants
RE
01/25Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVAVAX, INC.
01/26FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/25Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
01/20River Private Wealth announces new round of investment in Novavax, Inc
AQ
01/20Novavax, Inc. announced that it has received $6.75 million in funding from River Privat..
CI
01/18Novavax Says South Korea Partner Obtained Approval for Use of COVID-19 Vaccine as Adult..
MT
01/18Novavax COVID-19 Jab Gets South Korea's OK as Booster for Adults
MT
01/18Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
PR
01/09Transcript : Novavax, Inc. Presents at 41st Annual J.P. Morgan Healthcare Con..
CI
01/09Novavax Appoints John Jacobs as CEO
MT
01/09Novavax's longtime CEO Stanley Erck to retire
RE
01/09Novavax Names John C. Jacobs as New President & Chief Executive Officer
PR
01/09Novavax, Inc. Announces Management Changes
CI
01/09Novavax, Inc. Announces Chief Executive Officer Changes
CI
01/09Novavax CEO Stanley Erck to retire
RE
01/09Novavax : to Participate in the 41st Annual J.P. Morgan Healthcare Conference
PU
More most relevant news
All news about NOVAVAX, INC.
01/26FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/26Novavax needs 6 months to produce annual COVID shots that match new variants
RE
01/25Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
01/20River Private Wealth announces new round of investment in Novavax, Inc
AQ
01/20Novavax, Inc. announced that it has received $6.75 million in funding from River Privat..
CI
01/18Novavax Says South Korea Partner Obtained Approval for Use of COVID-19 Vaccine as Adult..
MT
01/18Novavax COVID-19 Jab Gets South Korea's OK as Booster for Adults
MT
01/18Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
PR
01/10MarketScreener's World Press Review: January 10
MS
01/10North American Morning Briefing: More Hawkish Fed -2-
DJ
More news
News in other languages on NOVAVAX, INC.
01/26Novavax busca un período de 6 meses para producir vacunas COVID que coincidan con las n..
01/18Novavax déclare que son partenaire sud-coréen a obtenu l'autorisation d'utiliser le vac..
01/18Novavax COVID-19 Jab reçoit l'aval de la Corée du Sud en tant que rappel pour les adult..
01/18Novavax : approbation du vaccin Covid comme rappel en Corée
01/13ANALYSEN DES TAGES von Dow Jones Newswires (13.01.2023)
01/10Presse Rundblick - Dienstag, 10. Januar
01/104 minutos de mercados del martes 10 de enero
01/10Cronache di Borsa - Martedì 10 gennaio
01/10CUREVAC, NOVAVAX : grand remaniement des directions, embauches chez San..
01/10AstraZeneca prend CinCor, Apple abandonne Broadcom ..
More news
Analyst Recommendations on NOVAVAX, INC.
01/09B. Riley Lowers Novavax's Price Target to $37 From $74, Keeps Buy Rating
MT
2022B. Riley Lowers Novavax's Price Target to $74 From $83, Keeps Buy Rating
MT
2022B. Riley Lowers Novavax's PT to $83 From $126 to Reflect Current Realities of COVID Boo..
MT
2022JPMorgan Downgrades Novavax to Underweight from Neutral, Adjusts Price Target to $27 fr..
MT
2022B. Riley Securities Lowers Novavax's Price Target to $126 from $171 After Lower-than-Ex..
MT
More recommendations
Press releases
01/25Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
01/20River Private Wealth announces new round of investment in Novavax, Inc
AQ
01/18Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
PR
01/09Novavax Inc : Change in Directors or Principal Officers, Regulation FD Disclosure, Financi..
AQ
01/09Novavax Names John C. Jacobs as New President & Chief Executive Officer
PR
More press releases
Analysis
Novavax cuts full-year revenue forecast
Upcoming event on NOVAVAX, INC.
02/27/23FY 2022 Earnings Release (Projected)
Upcoming sector events
02/09/23ALNYLAM PHARMACEUTICALS, INC. : FY 2022 Earnings Release (Projected)
02/10/23IQVIA HOLDINGS INC. : FY 2022 Earnings Release
02/15/23SEAGEN INC. : FY 2022 Earnings Release
02/23/23MODERNA, INC. : FY 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research